Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting

Tierney, Hannah; Takimoto, Sarah; Azari, Soraya; Steiger, Scott; Martin, Marlene

doi:10.1080/10826084.2023.2212070

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, the optimal time for retention in SU treatment is not well-defined as evident by the range of timelines applied to analyze retention. 25 , 34 , 35 Our analysis supports the need to better understand such drop offs through future qualitative work and larger epidemiologic studies for robust data on SU and treatment patterns to develop an evidence base which can address these gaps and inform appropriate benchmarks. Future studies must investigate how achievement of benchmarks in the SU and HIV care continuums overlap and differ to guide integrated care strategies in HIV, sexual health, and primary care settings.…”

Section: Discussionmentioning

confidence: 60%

Brief Report: Substance Use Care Continuum in Women With and Without HIV in the Southern United States

Ramakrishnan,

Fujita,

Mehta

et al. 2024

JAIDS Journal of Acquired Immune Deficiency Syndromes

View full text Add to dashboard Cite

Background: Substance use (SU) contributes to poor outcomes among persons living with HIV. Women living with HIV (WWH) in the United States are disproportionately affected in the South, and examining SU patterns, treatment, and HIV outcomes in this population is integral to addressing HIV and SU disparities.Methods: WWH and comparable women without HIV (WWOH) who enrolled 2013-2015 in the Women's Interagency HIV Study Southern sites (Atlanta, Birmingham/Jackson, Chapel Hill, and Miami) and reported SU (self-reported nonmedical use of drugs) in the past year were included. SU and treatment were described annually from enrollment to the end of follow-up. HIV outcomes were compared by SU treatment engagement.Results: At enrollment, among 840 women (608 WWH, 232 WWOH), 18% (n = 155) reported SU in the past year (16% WWH, 24% WWOH); 25% (n = 38) of whom reported SU treatment. Over time, 30%, 21%, and 18% reported SU treatment at 1, 2, and 3 years, respectively, which did not significantly differ by HIV status. Retention in HIV care did not differ by SU treatment. Viral suppression was significantly higher in women who reported SU treatment only at enrollment (P = 0.03). Conclusions:We identified a substantial gap in SU treatment engagement, with only a quarter reporting treatment utilization, which persisted over time. SU treatment engagement was associated with viral suppression at enrollment but not at other time points or with retention in HIV care. These findings can identify gaps and guide future strategies for integrating HIV and SU care for WWH.

show abstract

Section: Discussionmentioning

confidence: 60%